Back to search

Article

Off Label Use of Tenecteplase in the Management of High-Risk Pulmonary Embolism

2024-05-24

Abstract excerpt

<h4>Background: </h4> Pulmonary embolism (PE) is a common multifactorial disease, but high-risk PE s a life-threatening condition associated with high mortality and morbidity and a heavy prognostic burden. Systemic thrombolysis is the first-line treatment approach for severe high-risk PE, but only few agents are indicated for use by international guidelines. Tenecteplase, a thrombolytic agent, is proven to reduce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
200edcb0-f43e-5d74-97b2-c1244bdf2de7
DOI
10.20944/preprints202405.1536.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Off Label Use of Tenecteplase in the Management of High-Risk Pulmonary EmbolismDOI 10.20944/preprints202405.1536.v1
Select a neighboring publication to make it the new centre.